Genmab — August 2018
-
the article is from januari, but hey, it is Agurketid
full text https://www.jmcp.org/doi/10.18553/jmcp.2018.24.1.29 -
Preclinical evaluation of DuoBody CD3xCD20 to be presented by Ida Hiemstra 14th November 14:35 at conference in Lisbon https://www.pegsummiteurope.com/advancing-bispecifics
-
Optimizing Early Sequencing and Treatment in MM https://www.onclive.com/peer-exchange/myeloma-next-gen-regimens/optimizing-early-sequencing-and-treatment-in-mm
-
-
God morgen og tak til lenk1.

-
-
Nyheden er et par dage gammel. Morphysos offentliggjorde den
i forbindelse med deres regnskab i onsdags. -
Så intet nyt der.
-
Kortsigtet er det MAIA data som skal sætte retningen. Og her er muligheden for upside vel betydelig større end downside, da vi venter gode data.
-
Var det ikke også omkring 10% aktien steg sidste år i august,
da Alcyone data blev offentliggjort?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind